Product Console

Operational Efficiency

SCRIMED resolves gaps, inefficiencies, and bottlenecks through owned controls and proof routes.

This lane turns scattered release, route, reliability, growth, enterprise, audit, and boundary constraints into one operating map with owners, hard stops, sprints, and retained approval gates.

Statusoperational-efficiency-bottleneck-resolution-control-plane-active
Records155
Open bottlenecks106
Proof routes87
Hard stops316
Sprints9
Triage items8

Boundary

Efficiency work can move faster without crossing authority boundaries.

SCRIMED Operational Efficiency organizes known gaps, inefficiencies, bottlenecks, fault classes, release gates, onboarding and communication handoffs, scalability constraints, API contract gaps, UI command friction, AI model-route limits, agent approval gates, evidence retrieval constraints, SLO/SLA and support boundaries, growth constraints, enterprise controls, and continuous-review hard stops into one operating resolution lane. It improves execution discipline only. It does not authorize autonomous production remediation, bypass AAL2, process PHI, approve live clinical care, certify security, certify accessibility, send email, create calendar invites, approve contracts, create public API SLAs, create contractual SLAs, guarantee uptime, approve live autonomous AI, approve production model routing, commit managed-service coverage, approve production hosting or residency, provide legal/accounting/tax advice, approve production connectors, guarantee revenue, guarantee profit margin, approve buyer release, claim trillion-dollar-scale equivalence, or replace qualified human review.

01resolved: 4
02active-control: 27
03contained: 18
04operator-required: 63
05protected-gated: 2
06external-review-required: 35
07blocked-by-design: 6

Domains

Every bottleneck is assigned to a domain so it can be routed instead of rediscovered.

domain

release-quality

6 efficiency records are tracked for this operating domain.

Inspect records
domain

route-coverage

18 efficiency records are tracked for this operating domain.

Inspect records
domain

service-reliability

18 efficiency records are tracked for this operating domain.

Inspect records
domain

offering-packaging

8 efficiency records are tracked for this operating domain.

Inspect records
domain

client-onboarding

14 efficiency records are tracked for this operating domain.

Inspect records
domain

enterprise-scalability

16 efficiency records are tracked for this operating domain.

Inspect records
domain

platform-power

19 efficiency records are tracked for this operating domain.

Inspect records
domain

limitations-workarounds

20 efficiency records are tracked for this operating domain.

Inspect records
domain

commercial-throughput

4 efficiency records are tracked for this operating domain.

Inspect records
domain

enterprise-operations

20 efficiency records are tracked for this operating domain.

Inspect records
domain

continuous-review

6 efficiency records are tracked for this operating domain.

Inspect records
domain

health-records-safety

5 efficiency records are tracked for this operating domain.

Inspect records
domain

boundary-control

1 efficiency records are tracked for this operating domain.

Inspect records

Discrepancy and fault triage

Conflicting signals, recurring errors, and fault patterns now have a containment path before release or buyer use.

critical

A public page, API route, Product Console count, docs entry, or smoke assertion no longer agrees with the source route inventory.

Navigation, Product Console, API response, README, docs, and smoke can drift when a new route or control is added in only one surface.

Freeze external release language for the affected surface and run route inventory, typecheck, build, and public smoke before promotion.
  • Root cause: Compare Navigation Audit page/API counts, Product Console proof stack, route handlers, docs, and smoke expectations for the missing route or count.
  • Permanent control: Every buyer-critical route must update navigation, Product Console, route/API brief, docs, and smoke in the same release.
  • Owner: Release Steward + Product Console + Navigation Audit
  • Trigger: Any page/API count mismatch, missing smoke coverage, or Product Console count regression.
  • Proof: /navigation, /product, /release-continuity, /operational-efficiency
  • Route alignment is release evidence only; it does not approve protected execution, PHI, connectors, or clinical use.
critical

Protected API returns an unexpected status, exposes data without AAL2, or fails differently between local and branded production.

Local sandbox, production auth, and protected workspace behavior can differ, especially around 401 versus 503 fail-closed responses.

Treat the protected path as unavailable for external proof until fail-closed behavior, AAL2 requirement, and no-secret boundaries are verified.
  • Root cause: Check auth guard, workspace slug, token path, environment variables, protected route handler, and smoke fail-closed expectation.
  • Permanent control: Keep protected route smoke tolerant only of approved fail-closed statuses while requiring authenticated happy-path evidence from a human AAL2 session.
  • Owner: TrustOS + Security + Release Steward
  • Trigger: Any protected route returns 200 without approved auth or changes fail-closed status without documented reason.
  • Proof: /pilot-workspace/access, /qa-buyer-proof-release, /release-continuity, /service-reliability
  • Fail-closed verification does not bypass AAL2, create customer permission, or authorize buyer proof release.
critical

Public, buyer, investor, demo, or API copy implies certification, PHI authority, ROI, live clinical use, uptime, or autonomous remediation.

Growth copy can outpace retained evidence when marketing, sales, investor, and product surfaces are edited independently.

Route the claim through Claim Guard and Boundary Resolution, replace the language with current-state proof, and block release until reviewed.
  • Root cause: Search changed copy for prohibited claims and compare against hard stops in Company Assessment, Clinical Production Readiness, and Boundary Resolution.
  • Permanent control: Every strategic copy change must include approved no-authority language and a proof route before it is exposed to buyers or investors.
  • Owner: Claim Guard + Legal Ops + Product Marketing
  • Trigger: Any unsupported legal, financial, clinical, security, PHI, connector, SLA, revenue, or certification claim.
  • Proof: /qa-claim-guard, /boundary-resolution, /company-assessment, /clinical-production-readiness
  • Claim triage is not legal advice, certification, security assurance, audited financial reporting, or clinical validation.
high

A demo, pilot, assessment, diligence request, meeting follow-up, or proposal lacks owner, next action, package, or response SLA.

Client onboarding, service delivery, pricing, sales operations, and enterprise deal desk can diverge if buyer motion is not forced into one package path.

Assign the buyer stage, package, owner, follow-up SLA, no-PHI intake route, and deal-desk review before any new commitment is made.
  • Root cause: Check Client Onboarding stage, Service Delivery work order, Offering package, Pricing path, and Enterprise Business Ops review status.
  • Permanent control: Every buyer handoff must resolve to one of: no-PHI assessment, synthetic pilot, protected enterprise pilot, diligence package, license, or retainer.
  • Owner: Revenue Operations + Customer Operations + Deal Desk
  • Trigger: Any buyer record stays ownerless, unpriced, unscoped, or without next action after the review window.
  • Proof: /client-onboarding, /service-delivery, /offerings, /enterprise-business-ops
  • Buyer handoff control does not send email, create invites, approve contracts, or guarantee revenue.
high

Buyer or investor language implies production SLA, managed service, uptime, global region support, tenant capacity, or incident response readiness.

Enterprise scalability, service reliability, platform power, finance, and legal review can move at different speeds during expansion conversations.

Replace commitment language with readiness language and route the request through scale, support, cost, legal, and deal-desk owners.
  • Root cause: Review capacity assumption, support tier, SLO/SLA boundary, incident/change path, regional gate, cost guardrail, and contract authority.
  • Permanent control: No scale or support promise leaves SCRIMED without tenant owner, queue/backpressure model, incident path, support tier, cost guardrail, and no-SLA boundary.
  • Owner: Enterprise Scalability + Service Reliability + Finance + Legal Ops
  • Trigger: Any unsupported SLA, uptime, managed service, region, production support, or capacity claim appears in external language.
  • Proof: /enterprise-scalability, /service-reliability, /platform-power, /enterprise-business-ops
  • Scale triage is not contractual SLA approval, uptime guarantee, managed-service commitment, hosting approval, or profit assurance.
critical

Health-record, EHR, HIE, payer, imaging, device, patient matching, or writeback requests move beyond no-PHI sandbox planning.

Interoperability readiness can be mistaken for production connector authority if live data, credentials, or patient-impacting steps are requested.

Reject live PHI, credentials, endpoints, patient matching, payer submission, and writeback until customer authority and qualified review exist.
  • Root cause: Classify the data type, standard, source system, patient-safety impact, connector authority, PHI scope, and customer approval evidence.
  • Permanent control: Every integration conversation must start with no-PHI fixtures, standards map, source attribution, patient-safety lint, and live-data gate list.
  • Owner: Interoperability + Health Records Safety + Privacy + Clinical Governance
  • Trigger: Any live data, credential, writeback, payer submission, patient matching, or production connector request.
  • Proof: /health-records, /interoperability, /clinical-authority-readiness, /clinical-production-readiness
  • Interoperability triage is not PHI authority, connector approval, payer submission approval, EHR mutation approval, or live care.
high

Agent, model-route, review-loop, or innovation language implies autonomous production action, live clinical judgment, public quantum capability, or unmanaged remediation.

Internal innovation and continuous review can be misread as public autonomous capability when controls are not explicit.

Keep the pathway internal or human-gated, block public quantum/autonomous claims, and require evaluation plus owner approval before promotion.
  • Root cause: Inspect model route, tool access, allowed data, blocked data, eval pack, human approval trigger, cost owner, and public language.
  • Permanent control: Every agent or model path must carry allowed data, blocked data, evaluation evidence, human approval trigger, and no-autonomous-authority boundary.
  • Owner: AI Platform + TrustOS + Internal Research Team
  • Trigger: Any agent or model path requests protected action, production remediation, live clinical judgment, or public quantum claim.
  • Proof: /platform-power, /continuous-review-audit, /agents, /evaluation
  • Agent triage is not live autonomous AI approval, production model routing, clinical authorization, or public quantum capability.
high

Custom scope, free diligence labor, discounting, payment terms, investor language, tax language, or revenue-recognition questions bypass deal desk.

Sales urgency can create margin leakage when finance, legal, accounting, tax, and delivery controls are not pulled into the same decision.

Pause proposal release, assign package and scope, run price-floor and margin review, and route finance/legal/tax/accounting exceptions.
  • Root cause: Review package, price floor, discount, work order, acceptance criteria, billing trigger, payment terms, tax implications, and blocked claims.
  • Permanent control: Every enterprise proposal must include margin model, billing readiness, contract authority, tax/accounting triage, and blocked-claim review.
  • Owner: Finance + Deal Desk + Legal Ops + Revenue Operations
  • Trigger: Any unpriced custom work, margin exception, financial claim, investor claim, or unreviewed payment term.
  • Proof: /enterprise-business-ops, /capital-vitality, /service-delivery, /growth-engine
  • Finance triage is not accounting advice, tax advice, audited financial reporting, securities material, valuation assurance, or revenue guarantee.

Resolution Sprints

Focused sprints turn known friction into repeatable operating controls.

Release Steward + Product Console

Release and route preflight

Prevent route drift, missing smoke coverage, stale boundary headers, and untracked protected gates before deployment.

Fewer release regressions and faster go/no-go decisions.
  • Update route inventory and smoke-covered HTML routes
  • Run typecheck, lint, build, and public smoke
  • Verify boundary headers on buyer-critical APIs
  • Retain Vercel deploy and custom-domain smoke evidence
Founder + Revenue Operations

Commercial throughput

Shorten the path from qualified buyer interest to scoped, priced, and governed next action.

Less custom-sales drag, clearer price floors, and fewer margin leaks.
  • Attach each buyer to one package, one offer, one proof route, one margin control, and one disqualifier check
  • Route non-standard terms through deal desk
  • Price diligence and implementation work explicitly
  • Keep ROI, reimbursement, and revenue claims behind reviewed evidence
Revenue Operations + Sales Engineering + Customer Operations

Client onboarding and communication cadence

Turn buyer interest into governed discovery, demo, pilot, diligence, kickoff, and renewal communication without losing owners or crossing authority boundaries.

Faster first response, tighter demo follow-up, cleaner pilot scoping, and fewer informal commitments.
  • Classify the buyer stage and selected package
  • Use a human-reviewed email or calendar-ready packet
  • Assign meeting owner, follow-up SLA, and handoff owner
  • Route PHI, security, contract, procurement, legal, finance, or clinical requests to the proper boundary owner
Platform + service reliability + customer operations

Enterprise scalability and support readiness

Prevent enterprise traffic, tenant growth, support expectations, SLO/SLA language, regional hosting, incident response, and usage costs from outpacing evidence.

Fewer unsupported scale promises, cleaner support economics, and faster enterprise readiness review.
  • Attach capacity forecast, route class, queue/backpressure controls, and rollback path
  • Review tenant owner, access cadence, AAL2 path, support tier, and escalation matrix
  • Keep SLO language internal until contract and staffing review approve exact commitments
  • Route regional hosting, residency, DR, and cost thresholds to qualified owners
Platform engineering + Product Console + AI platform + TrustOS

API, UI, and AI platform power

Raise SCRIMED's platform power through contract-backed APIs, operator-grade UI, model-route readiness, agent approval workflows, eval loops, evidence retrieval, and cost telemetry.

Sharper enterprise technical diligence, less UI friction, clearer AI authority, and stronger cost discipline.
  • Promote buyer-critical APIs into an owner, schema, version, auth, boundary, and smoke contract register
  • Make platform-power routes visible in primary nav, hub, product console, role journeys, and limitation controls
  • Attach every model or agent path to allowed data, blocked data, eval pack, human approval trigger, and cost owner
  • Route public API SLA, live AI, PHI, accessibility, security, and trillion-scale claims through Boundary Resolution
Boundary owner + Operational Efficiency + Product Console

Limitations workaround containment

Turn blocked requests, boundaries, issues, and repeated bottlenecks into safe packets, escalation owners, proof routes, expiration rules, and graduation gates.

Less stalled work, fewer informal exceptions, and clearer safe paths when authority is missing.
  • Classify issue by category, severity, state, owner, and proof route
  • Select the reusable workaround packet or create a new one with hard stops
  • Attach escalation trigger, expiry rule, and graduation gate
  • Promote repeated workarounds into smoke, navigation, boundary, platform, reliability, or service controls
QA Regression Agent + TrustOps

Continuous defect-to-control loop

Turn repeated mistakes, buyer questions, incidents, and source drift into deterministic controls.

Fewer repeated defects and clearer accountability for each new risk.
  • Classify the defect or near miss
  • Attach owner, route, and hard stop
  • Add or update smoke coverage where deterministic
  • Promote recurring patterns into the boundary or reliability register
Interoperability + TrustOS + clinical governance

Health-record extraction and safety

Turn buyer health-record, EHR, HIE, payer, imaging, and document requests into no-PHI extraction plans with safety checks and retained live-data gates.

Faster integration scoping with fewer unsafe data asks and clearer customer sandbox workarounds.
  • Classify source format and standard bindings
  • Reject PHI, identifiers, production credentials, live endpoints, and record mutation requests
  • Run synthetic extraction planning and patient-safety lint
  • Route sandbox, PHI, connector, clinical, payer, and writeback gates to named owners
Finance + Legal Ops + Deal Desk

Enterprise margin and control discipline

Stop margin leakage, unfunded diligence labor, weak payment terms, and unsupported business claims before proposals leave SCRIMED.

Better cash discipline and fewer unpriced enterprise commitments.
  • Run price-floor and margin review
  • Confirm scope, SOW, billing trigger, and payment terms
  • Route accounting, tax, securities, and counsel exceptions
  • Retain approval evidence and blocked-claim language

Priority Bottlenecks

Open records keep their hard stops visible until the retained path is complete.

operator-required

Protected AAL2 happy path

A terminal cannot safely create or retain a fresh human AAL2 bearer token without crossing the no-secret boundary.

Use the protected browser workspace for no-secret verification, or run the CLI smoke only with a fresh external AAL2 token and dispose of it immediately after the run.
  • Owner: Approved tenant-admin or pilot-lead operator
  • Source: Release Continuity
  • Proof: /pilot-workspace/access, /buyer-release-control-run, /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run
operator-required

AAL2 smoke readiness packet

A release checklist can prove readiness surfaces exist, but it cannot prove authenticated protected writes without a fresh human AAL2 session.

Inspect /api/qa-evidence/aal2-smoke-readiness, run npm run smoke:aal2:readiness, then use a short-lived authorized AAL2 token only for deliberate strict smoke.
  • Owner: Release Steward + Approved AAL2 Operator
  • Source: Release Continuity
  • Proof: /qa-aal2-run-evidence, /api/qa-evidence/aal2-smoke-readiness, /api/qa-evidence/aal2-smoke-readiness/brief
blocked-by-design

Secret handling

Automating protected happy-path evidence with stored long-lived tokens would weaken the trust boundary.

Prefer browser AAL2 operator panels; when CLI evidence is necessary, use explicit environment variables for one run and never write token values to docs, chat, CI logs, or code.
  • Owner: Security + Operator
  • Source: Release Continuity
  • Proof: /qa-run-control, /qa-launch-kit, /qa-human-run-packet
external-review-required

Regulated approval claims

SCRIMED can prepare approval evidence, but it cannot self-certify or self-authorize regulated claims.

Route public copy through Claim Guard, keep intended use narrow, retain external approval references, and require qualified reviewer sign-off before any claim expansion.
  • Owner: Founder + Legal/Security/Regulatory reviewers
  • Source: Release Continuity
  • Proof: /approvals-readiness, /boundary-resolution, /qa-claim-guard
external-review-required

Clinical production readiness incompleteness

Current no-PHI pilots, demos, diligence packets, and readiness services are usable now, but clinical production requires a separate task ledger, qualified external review, customer authority, and live-data controls.

Use /clinical-production-readiness before PHI, live-care, connector, clinical AI, certification, customer go-live, or global production language expands; use current capability motions for safe revenue while the task ledger remains incomplete.
  • Owner: Clinical production readiness owner + qualified external reviewers
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
operator-required

Protected happy-path proof

Unauthenticated checks can prove fail-closed behavior, but not successful tenant-scoped protected mutations.

Use /pilot-workspace/access with an active human AAL2 browser session or a deliberate one-time short-lived token run without retaining token values.
  • Owner: Approved tenant-admin or pilot-lead operator
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

External approvals and certifications

Navigation can show approval and certification tracks, but SCRIMED cannot self-certify legal, security, HIPAA, FDA, ONC, EU AI Act, GDPR, NHS, MHRA, Australia, reimbursement, procurement, or clinical-use authority.

Keep approval and certification routes claims-controlled, attach only qualified external evidence, and preserve no-authority headers until formal approval exists.
  • Owner: Founder + qualified external reviewers
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

Capital and securities boundaries

Revenue, moat, investor, and funding readiness can be mistaken for securities offering material, audited financial reporting, valuation assurance, or investment advice.

Use /capital-vitality for readiness-only proof, keep no-securities/no-advice headers visible, and route fundraising, valuation, legal, tax, and investor-solicitation materials through qualified counsel.
  • Owner: Founder + qualified counsel + finance reviewers
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
operator-required

Growth execution concentration

Proof depth can diffuse commercial focus unless buyer segments, sellable offers, conversion lanes, and next actions stay prioritized.

Use /growth-engine to keep founder-led assessment outreach, synthetic pilot pipeline, governance audit packaging, and protected diligence upgrades in one operating lane.
  • Owner: Founder + Product Console + Sales Operations
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

Enterprise legal and finance operating depth

Enterprise revenue, margins, contracts, accounting, tax, investor, and board materials can create risk if authority is informal or claims outrun qualified review.

Use /enterprise-business-ops to route deal desk, price floors, margin controls, legal/accounting/tax roles, billing readiness, and blocked business claims through named owners before commitments expand.
  • Owner: Founder + qualified counsel + finance/accounting/tax reviewers
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

Enterprise scalability commitment boundaries

Capacity, SLO, support, region, residency, disaster recovery, and managed-service language can become accidental commitments if not routed before buyer use.

Use /enterprise-scalability to attach capacity assumptions, tenant owners, support-tier review, no-SLA language, regional gates, cost thresholds, and qualified contract review before commitments expand.
  • Owner: Platform + service reliability + customer operations + legal ops
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

API UI AI platform power authority boundaries

API contracts, UI improvements, live AI, model routing, agent tool use, accessibility, and scale-positioning language can become unsupported enterprise claims if they are not routed through proof and authority controls.

Use /platform-power to attach API owners, UI role journeys, model-route registers, agent approval triggers, eval evidence, cost owners, and no-live-AI/no-PHI/no-SLA boundaries before claims expand.
  • Owner: Platform engineering + Product Console + TrustOS + security + finance
  • Source: Navigation Audit
  • Proof: /navigation, /api/navigation-audit, /api/navigation-audit/brief
external-review-required

Clinical, legal, security, and approval authority

SCRIMED can prepare approval evidence but cannot self-certify HIPAA, SOC 2, HITRUST, FDA, ONC, legal, reimbursement, or clinical authority.

Route claims and buyer-specific evidence through external review before expanding public language.
  • Owner: Founder + qualified external reviewers
  • Source: Approvals Readiness, Clinical Authority, Boundary Resolution
  • Proof: /approvals-readiness, /clinical-authority-readiness, /boundary-resolution, /qa-claim-guard
operator-required

Manual AAL2 protected proof

Public checks prove fail-closed behavior, but authenticated protected mutations require a fresh human AAL2 session.

Use the browser AAL2 workspace for protected proof or a deliberate one-time token run with no retention.
  • Owner: Approved tenant-admin or pilot-lead operator
  • Source: Protected Pilot Workspace, QA Evidence, Buyer Release Control
  • Proof: /pilot-workspace/access, /qa-manual-execution-console, /qa-run-control, /qa-human-run-packet, /buyer-release-control-run
protected-gated

Buyer release and external sharing

Buyer-specific external sharing requires retained release decisions, named reviewer signoffs, recipient controls, authority attestations, and access-log reconciliation.

Complete the release-control chain before any buyer-specific external distribution.
  • Owner: Buyer Diligence + Release Steward + qualified reviewers
  • Source: Buyer Release Control, protected release verifier, distribution lockbox
  • Proof: /buyer-release-control-run, /pilot-workspace/access#buyer-release-control-verifier, /api/pilot-workspaces/{workspaceSlug}/buyer-release-control-run
external-review-required

Public market and global expansion

Financial, regional, procurement, reimbursement, and legal claims can outpace current evidence without external review.

Keep public-market, procurement, and regional expansion claims qualified until external evidence is retained.
  • Owner: Founder + Finance + Global Partnerships + qualified regional reviewers
  • Source: Public Market Readiness, Global Reach, Deployment Profiles
  • Proof: /public-market-readiness, /global-reach, /deployment-profiles, /market-activation
operator-required

Protected token handling

Attempting to automate AAL2 protected proof with retained bearer tokens.

Reject token storage and require a fresh human AAL2 session or one-time external token disposal.
  • Owner: Release Steward + domain owner
  • Source: Service Reliability
  • Proof: /qa-run-control, /qa-launch-kit, /qa-manual-execution-console
operator-required

External approval overclaim

Copy, buyer materials, or operator notes implying certification, legal approval, PHI authority, or live-care authority.

Downgrade to readiness language and route to qualified external review.
  • Owner: Release Steward + domain owner
  • Source: Service Reliability
  • Proof: /approvals-readiness, /boundary-resolution, /qa-claim-guard